Telomere length in young and middle-aged patients: relationship with cardiovascular risk factors-Reference-Cited by-同舟云学术

Telomere length in young and middle-aged patients: relationship with cardiovascular risk factors

Published:2024-08-25 Issue:7 Volume:29 Page:5905
ISSN:2618-7620
Container-title:Russian Journal of Cardiology
language:
Short-container-title:Russ J Cardiol

Author:

Podzolkov V. I.¹^ORCID,Bragina A. E.¹^ORCID,Druzhinina N. A.¹^ORCID,Vasilyeva L. V.¹^ORCID,Shikhmagomedov R. A.¹^ORCID,Averyeva E. M.¹^ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University

Abstract

Aim. To evaluate the relationship between leukocyte telomere length (LTL) and cardiovascular risk factors in young and middle-aged patients without cardiovascular disease (CVD).Material and methods. This cross-sectional study involved 450 patients aged 30 [21;42] years. Risk factors and possible exclusion criteria was assessed through questionnaires and anthropometric examination. In all subjects, glucose concentration and lipid profile were assessed using the CardioChekPA express analyzer (USA, 2017), followed by calculation of integral metabolic indices: visceral adiposity index (VAI), body fat percentage, body adiposity index (BAI), lipid accumulation product (LAP). LTL was measured in whole blood samples using fluorimetry (Qubit 4 Singapore 2020) and reverse transcription polymerase chain reaction (QIAamp Blood Mini Kit, German 2022). Statistical analysis was carried out using the Statistica 10 program.Results. The prevalence of the studied risk factors in the main group corresponded to the general population. According to the correlation analysis, LTL was associated with age (r=-0,26; p<0,05), smoking (r=-0,35; p<0,05), obesity (r=-0,19; p>0,05), neck circumference (NC) (r=-0,53; p<0,05), diastolic blood pressure (r=-0,31; p<0,05), cholesterol (r=-0,64; p<0,05), high-density lipoproteins (HDL) (r=0,59; p<0,05) and low-density lipoproteins (r=-0,52; p<0,05), triglycerides (r=-0,46; p<0,05), glucose (r=-0,33; p<0,05), LAP (r=-0,4; p<0,05), VAI (r=-0,57; p<0,05) and BAI (r=-0,32; p<0,05). According to the multivariate regression analysis, LTL was associated with age (B=-0,04, Std. Err. of B=0,02, p=0,03), smoking (B=-0,87, Std. Err. of B=0,26, p=0,001), NC (B=-0,23, Std. Err. of B=0,07, p=0,001), total cholesterol levels (B=-0,37, Std. Err. of B=0,87, p<0,001), HDL (B=0,59, Std. Err. of B=0,24, p=0,018), LAP (B=-0,01, Std. Err. of B=0,02, p<0,011), VAI (B=-0,37, Std. Err. of B=0,16, p=0,025).Conclusion. LTL is interconnected with cardiovascular risk factors, which determines the significance of their participation in CVD development and biological aging in young and middle-aged people.

Publisher

Silicea - Poligraf, LLC

Reference22 articles.

1. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):122349. doi:10.1016/S01406736(20)307522.

2. Balanova YA, Shalnova SA, Imaeva AE, et al. Prevalence, awareness, treatment and control of hypertension in Russian Federation (data of observational ESSE RF2 study). Rational Pharmacotherapy in Cardiology. 2019;15(4):45066. (In Russ.) doi:10.20996/181964462019154450466.

3. Balanova YA, Shalnova SA, Deev AD, et al. Obesity in Russian population — prevalence and association with the noncommunicable diseases risk factors. Russian Journal of Cardiology. 2018;(6):12330. (In Russ.) doi:10.15829/1560407120186123130.

4. Grinstein YI, Shabalin VV, Ruf RR, et al. Prevalence of dyslipidemia among the population of a large region of Eastern Siberia and the relationship with sociodemographic and behavioral factors. Preventive Medicine 2018;21(5):639. (In Russ.) doi:10.17116/profmed20182105163.

5. Santos AL, Sinha S. Obesity and aging: Molecular mechanisms and therapeutic approaches. Ageing Res Rev. 2021;67:101268. doi:10.1016/j.arr.2021.101268.